Common Shares Outstanding: The number of class A shares currently held by investors.
Athira Pharma, Inc. (ATHA) had Common Shares Outstanding of 38.17M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-117.67M |
|
-- |
|
-- |
|
$125.47M |
|
$-125.47M |
|
$7.79M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-125.47M |
|
$-125.91M |
|
38.02M |
|
38.02M |
|
$-3.09 |
|
$-3.09 |
|
| Balance Sheet Financials | |
$154.73M |
|
$3.39M |
|
$5.52M |
|
$160.25M |
|
$28.84M |
|
-- |
|
$1.22M |
|
$30.06M |
|
$130.19M |
|
$130.19M |
|
$130.19M |
|
|
Common Shares Outstanding |
38.17M |
| Cash Flow Statement Financials | |
$-100.75M |
|
$95.09M |
|
$0.49M |
|
$96.39M |
|
$91.22M |
|
$-5.17M |
|
$10.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-101.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-90.39% |
|
-90.39% |
|
-73.43% |
|
-90.39% |
|
$3.41 |
|
$-2.66 |
|
$-2.65 |
|